Ray Chan, M.D.
Ophthalmology Physician in Arlington, Texas.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 22,388 in Ophthalmology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Ray Chan, M.D. reported a CMS MIPS final score of 74.6/100 - below the 83.5 national average - and filed 586 Medicare Part D claims in 2024.
- 74.6/100
- MIPS score · -9 vs avg
- 586
- Part D claims, 2024
- 50%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Ray Chan, M.D.
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1548268162), first enumerated 07/08/2005.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 586 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 74.6/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- State context
State board disciplinary context
Texas statewide board action statistics are published annually — these figures describe aggregate state activity, not Ray Chan, M.D.'s individual license status. Verify directly with the state medical board.
Source: TMB annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1548268162 · Ophthalmology Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-BELOW · RX-LIGHT · BOOK-LIGHT · PHOTO-FINISH
- NPI-10 1548268162
- ENUM-LEGACY 2005
- TAX-MID 22K Ophthalmology Physician
- MIPS-BELOW 74.6/100
- RX-LIGHT 586
- BOOK-LIGHT 1,439 in Texas
- PHOTO-FINISH Sami Kabbara, MD · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Chan · this prov…
Chan · this provider
74.6 MIPS pts
- Bhagvanji Meghpa…
Bhagvanji Meghpara, D.O.
74.6 MIPS pts
- Sami Kabbara, MD…
Sami Kabbara, MD
74.6 MIPS pts
- Ronald Mancini, …
Ronald Mancini, MD
74.6 MIPS pts
- Jill Brody, M.D.…
Jill Brody, M.D.
74.6 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Ray Chan, M.D.'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
75 ≥ 13th percentile 13% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Ray Chan, M.D. sits
This provider among ophthalmology physician peers
Across the 8,767 ophthalmology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Ray Chan, M.D. writes more Part D claims than 30% of them and scores higher on MIPS quality than 16% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one ophthalmology physician peer from a representative sample of 60; the gold marker is Ray Chan, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Ray Chan, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Ray Chan, M.D.?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Texas
How Ophthalmology Physician compares to other specialties among Texas providers
Ophthalmology Physician ranks #51 among Texas's specialties (0.3% of in-state providers)
Each bar is a specialty's share of the Texas provider total, by primary NUCC taxonomy. The highlighted bar is Ophthalmology Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Ray Chan, M.D.'s 2023 MIPS final score plotted against the Ophthalmology Physician national average
- MIPS Final Score
- 74.6/100
- vs 83.5 national avg · 2023 performance year
Quality benchmarks
- National MIPS avg 2023 measured reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Ophthalmology Physician US NPIs
74.6/100 MIPS final score - 8.9 pts below the 83.5 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Ophthalmology Physician. Quality dim: 56.1. Cost dim: 59.2.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1548268162 |
|---|---|
| Specialty | Ophthalmology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 07/08/2005 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Ray Chan, M.D.'s current license status, disciplinary history, and board certifications with the Texas Medical Board in Texas before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1548268162 is the unique 10-digit identifier CMS uses to link Chan across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
License & disciplinary context - Texas TMB 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 - they are NOT specific to Ray Chan, M.D.. To verify Ray Chan, M.D.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
50% brand-name claims vs 50% generic, on 586 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
Prescribing Breakdown
- 30-Day Fills
- 1,299.067
- Total Day Supply
- 38,207
- Brand vs Generic
- 50% brand / 50% generic
- Brand Drug Cost
- $97K
- Generic Drug Cost
- $10K
Patient Demographics
- Average Patient Age
- 75.5 years
- Avg HCC Risk Score
- 1.34
- Gender Split
- 59% female / 41% male
- Age Distribution
- <65: 11, 65-74: 74, 75-84: 72, 85+: 20
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Ray Chan, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Latanoprost
Latanoprost
230 claims
- Dorzolamide-Timolol
Dorzolamide-Timolol
96 claims
- Timolol Maleate 34
Timolol Maleate
34 claims
- Brimonidine Tartrate 33
Brimonidine Tartrate
33 claims
- Fluorometholone 28
Fluorometholone
28 claims
- Restasis 24
Restasis
24 claims
- Lumigan 22
Lumigan
22 claims
- Vyzulta 21
Vyzulta
21 claims
| Drug | Claims |
|---|---|
| Latanoprost | 230 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 96 |
| Timolol Maleate | 34 |
| Brimonidine Tartrate | 33 |
| Fluorometholone | 28 |
| Restasis Cyclosporine | 24 |
| Lumigan Bimatoprost | 22 |
| Vyzulta Latanoprostene Bunod | 21 |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 17 |
| Loteprednol Etabonate | 17 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Ophthalmology Physician Overview
How Ray Chan, M.D. fits within the Ophthalmology Physician landscape nationally.
Ray Chan, M.D.'s 586 claims are below the specialty average of 1,490.
Nationwide Ophthalmology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Chan, both outside Texas so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (74.6 here).
Same NPPES enumeration year (2005)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Ophthalmology Physician Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as Chan.
One of 1,439 Ophthalmology Physician providers enrolled in Texas, 5 are shown here.
Compare Ophthalmology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Ray Chan, M.D.'s specialty? ▼
How much does Ray Chan, M.D. prescribe under Medicare Part D? ▼
What is Ray Chan, M.D.'s Medicare quality score? ▼
Where is Ray Chan, M.D. located? ▼
What is Ray Chan, M.D.'s NPI number? ▼
Does Ray Chan, M.D. prescribe more brand-name or generic drugs? ▼
How many Ophthalmology Physician providers are there in the US? ▼
What drugs does Ray Chan, M.D. prescribe most often? ▼
Does Ray Chan, M.D. accept Medicare? ▼
How can I verify Ray Chan, M.D.'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.